Kalaris Therapeutics, Inc. - KLRS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | VP, Corporate Controller | A | A | 10,000.0 | 0.0 | 0.0 | 10,000.0 | View | |
| Aug 03, 2026 | — | A | A | 18,000.0 | 0.0 | 0.0 | 18,000.0 | View | |
| Jul 20, 2026 | Chief Financial Officer | A | A | 220,000.0 | 0.0 | 0.0 | 220,000.0 | View | |
| Jun 04, 2026 | — | A | A | 9,000.0 | 0.0 | 0.0 | 9,000.0 | View | |
| Jun 04, 2026 | — | A | A | 9,000.0 | 0.0 | 0.0 | 9,000.0 | View | |
| Jun 04, 2026 | — | A | A | 9,000.0 | 0.0 | 0.0 | 9,000.0 | View | |
| Jun 04, 2026 | — | A | A | 9,000.0 | 0.0 | 0.0 | 9,000.0 | View | |
| Jun 04, 2026 | — | A | A | 9,000.0 | 0.0 | 0.0 | 9,000.0 | View | |
| Jun 04, 2026 | — | A | A | 9,000.0 | 0.0 | 0.0 | 9,000.0 | View | |
| Jun 04, 2026 | — | A | A | 9,000.0 | 0.0 | 0.0 | 9,000.0 | View | |
| May 22, 2026 | — | J | A | 4,471.0 | 0.0 | 0.0 | 19,408.0 | View | |
| May 22, 2026 | — | J | A | 14,937.0 | 0.0 | 0.0 | 14,937.0 | View | |
| May 22, 2026 | — | J | D | 66,906.0 | 0.0 | 0.0 | 10,657,028.0 | View | |
| May 22, 2026 | — | P | A | 244,300.0 | 4.83 | 1,179,969.0 | 2,224,147.0 | View |